{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:46:46Z","timestamp":1791960406829,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.eprac.2025.09.201","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:43:47Z","timestamp":1759301027000},"page":"164-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study"],"prefix":"10.1016","volume":"32","author":[{"given":"Alberto","family":"Piasentier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Francesca","family":"Birtolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Turci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Vena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Morenghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucrezia MS.","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Balzarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio C.","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Berruti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Lughezzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Franzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"De Vincenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo A.","family":"Zucali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5380-2141","authenticated-orcid":false,"given":"Andrea G.","family":"Lania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gherardo","family":"Mazziotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.eprac.2025.09.201_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.eprac.2025.09.201_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"10.1016\/j.eprac.2025.09.201_bib3","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(18)30047-0","article-title":"Bone health during endocrine therapy for cancer","volume":"6","author":"Rachner","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2025.09.201_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10030530","article-title":"Testosterone and bone health in men: a narrative review","volume":"10","author":"Shigehara","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.eprac.2025.09.201_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/165215","article-title":"The endocrine role of estrogens on human male skeleton","volume":"2015","author":"Rochira","year":"2015","journal-title":"Int J Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2025.09.201_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1530\/eje.1.02088","article-title":"Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology","volume":"154","author":"Rochira","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.eprac.2025.09.201_bib7","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1210\/jc.2005-0183","article-title":"Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer","volume":"90","author":"Greenspan","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.09.201_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00198-018-4722-3","article-title":"Patients with prostate cancer and androgen deprivation therapy have increased risk of fractures-a study from the fractures and fall injuries in the elderly cohort (FRAILCO)","volume":"30","author":"Wallander","year":"2019","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.eprac.2025.09.201_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/pcan.2011.4","article-title":"Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis","volume":"15","author":"Serpa Neto","year":"2012","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eprac.2025.09.201_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2019.100252","article-title":"Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials","volume":"18","author":"Galvano","year":"2019","journal-title":"J Bone Oncol"},{"issue":"9596","key":"10.1016\/j.eprac.2025.09.201_bib11","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eprac.2025.09.201_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4081\/reumatismo.2016.870","article-title":"Guidelines for the diagnosis, prevention and management of osteoporosis","volume":"68","author":"Rossini","year":"2016","journal-title":"Reumatismo"},{"key":"10.1016\/j.eprac.2025.09.201_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbo.2017.03.001","article-title":"Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG","volume":"7","author":"Hadji","year":"2017","journal-title":"J Bone Oncol"},{"issue":"31","key":"10.1016\/j.eprac.2025.09.201_bib14","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1200\/JCO.19.01696","article-title":"Management of osteoporosis in survivors of adult cancers with nonmetastatic Disease: ASCO clinical practice guideline","volume":"37","author":"Shapiro","year":"2019","journal-title":"J Clin Oncol"},{"issue":"29","key":"10.1016\/j.eprac.2025.09.201_bib15","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1200\/JCO.20.00434","article-title":"Bone mineral density and FRAX score may not predict fracture risk in patients with cancer undergoing hormone deprivation therapies","volume":"38","author":"Dalla Volta","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eprac.2025.09.201_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2022.100421","article-title":"Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practice","volume":"33","author":"Mazziotti","year":"2022","journal-title":"J Bone Oncol"},{"issue":"19","key":"10.1016\/j.eprac.2025.09.201_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/nu14194148","article-title":"Definition, assessment, and management of vitamin D inadequacy: suggestions, recommendations, and warnings from the Italian society for osteoporosis, mineral metabolism and bone diseases (SIOMMMS)","volume":"14","author":"Bertoldo","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.eprac.2025.09.201_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12020-012-9691-2","article-title":"New advances in imaging osteoporosis and its complications","volume":"42","author":"Griffith","year":"2012","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.eprac.2025.09.201_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11657-019-0577-2","article-title":"Automated quantitative morphometry of vertebral heights on spinal radiographs: comparison of a clinical workflow tool with standard 6-point morphometry","volume":"14","author":"Engelke","year":"2019","journal-title":"Arch Osteoporos"},{"issue":"2","key":"10.1016\/j.eprac.2025.09.201_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bone.2005.04.003","article-title":"Prognostic utility of a semiquantitative spinal deformity index","volume":"37","author":"Crans","year":"2005","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.eprac.2025.09.201_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jocd.2013.08.004","article-title":"Executive summary of the 2013 international society for clinical densitometry position development conference on bone densitometry","volume":"16","author":"Schousboe","year":"2013","journal-title":"J Clin Densitom"},{"issue":"7","key":"10.1016\/j.eprac.2025.09.201_bib22","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s40618-023-02056-w","article-title":"Bone quality in endocrine diseases: determinants and clinical relevance","volume":"46","author":"Cianferotti","year":"2023","journal-title":"J Endocrinol Invest"},{"issue":"9992","key":"10.1016\/j.eprac.2025.09.201_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0140-6736(15)60995-3","article-title":"Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"386","author":"Gnant","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.eprac.2025.09.201_bib24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s00223-022-01011-w","article-title":"Real-world effectiveness of denosumab and bisphosphonates on risk of vertebral fractures in women with breast cancer undergoing treatment with aromatase inhibitors","volume":"111","author":"Mazziotti","year":"2022","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"10.1016\/j.eprac.2025.09.201_bib25","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/jbmr.3641","article-title":"Change in bone density and reduction in fracture risk: a meta-regression of published trials","volume":"34","author":"Bouxsein","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.eprac.2025.09.201_bib26","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.annonc.2020.07.019","article-title":"Bone health in cancer: ESMO clinical practice guidelines","volume":"31","author":"Coleman","year":"2020","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.eprac.2025.09.201_bib27","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s11912-023-01447-9","article-title":"Role of body composition in the prediction of skeletal fragility induced by hormone deprivation therapies in cancer patients","volume":"25","author":"Dalla Volta","year":"2023","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"10.1016\/j.eprac.2025.09.201_bib28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s40618-023-02150-z","article-title":"Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study","volume":"47","author":"Dalla Volta","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.eprac.2025.09.201_bib29","doi-asserted-by":"crossref","first-page":"e2350950","DOI":"10.1001\/jamanetworkopen.2023.50950","article-title":"Fat body mass and vertebral fracture progression in women with breast cancer","volume":"7","author":"Cosentini","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.eprac.2025.09.201_bib30","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1210\/clinem\/dgac489","article-title":"Effect of degarelix Administration on bone health in prostate cancer patients without bone metastases. The blade study","volume":"107","author":"Palumbo","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2025.09.201_bib31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1210\/jcem-40-3-367","article-title":"Aromatization of androgens by human abdominal and breast fat tissue","volume":"40","author":"Nimrod","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.09.201_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.exger.2010.09.014","article-title":"Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice","volume":"46","author":"Halade","year":"2011","journal-title":"Exp Gerontol"},{"issue":"5","key":"10.1016\/j.eprac.2025.09.201_bib33","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1210\/jc.2006-0572","article-title":"Relationship of obesity with osteoporosis","volume":"92","author":"Zhao","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.09.201_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1749-799X-6-30","article-title":"Effects of obesity on bone metabolism","volume":"6","author":"Cao","year":"2011","journal-title":"J Orthop Surg Res"},{"issue":"3","key":"10.1016\/j.eprac.2025.09.201_bib35","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s12020-023-03613-2","article-title":"Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic tool","volume":"83","author":"Mazziotti","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.eprac.2025.09.201_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2022.100465","article-title":"High prevalence of vertebral fractures at initiation of androgen deprivation therapy for prostate cancer","volume":"38","author":"van Oostwaard","year":"2023","journal-title":"J Bone Oncol"},{"issue":"4","key":"10.1016\/j.eprac.2025.09.201_bib37","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","article-title":"Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis","volume":"15","author":"Klotzbuecher","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.eprac.2025.09.201_bib38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12020-020-02277-6","article-title":"Morphometric vertebral fractures in patients with castration-resistant prostate cancer undergoing treatment with radium-223: a longitudinal study in the real-life clinical practice","volume":"69","author":"Mazziotti","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.eprac.2025.09.201_bib39","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12020-025-04275-y","article-title":"A practical use of bone turnover markers in management of patients with skeletal fragility","volume":"89","author":"Brunetti","year":"2025","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.eprac.2025.09.201_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jnci\/dji002","article-title":"Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors","volume":"97","author":"Brown","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.eprac.2025.09.201_bib41","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1002\/jbmr.492","article-title":"Denosumab and changes in bone turnover markers during androgen deprivation therapy for prostate cancer","volume":"26","author":"Smith","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.eprac.2025.09.201_bib42","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.eururo.2019.01.026","article-title":"Higher risk of fragility fractures in prostate cancer patients treated with combined Radium-223 and abiraterone: prednisone may be the culprit","volume":"75","author":"Dalla Volta","year":"2019","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.eprac.2025.09.201_bib43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1210\/jc.2011-2189","article-title":"Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer","volume":"97","author":"Attard","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2025.09.201_bib44","doi-asserted-by":"crossref","first-page":"R231","DOI":"10.1530\/EJE-17-0154","article-title":"Management of endocrine disease: risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects","volume":"177","author":"Mazziotti","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2025.09.201_bib45","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40618-023-02174-5","article-title":"Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors","volume":"47","author":"Antonini","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"10.1016\/j.eprac.2025.09.201_bib46","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00774-024-01537-z","article-title":"Temporal declines in bone mineral density and trabecular bone score during androgen deprivation therapy","volume":"42","author":"Hara","year":"2024","journal-title":"J Bone Miner Metab"},{"issue":"10","key":"10.1016\/j.eprac.2025.09.201_bib47","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s40618-022-01837-z","article-title":"Artificial intelligence-based radiomics on computed tomography of lumbar spine in subjects with fragility vertebral fractures","volume":"45","author":"Biamonte","year":"2022","journal-title":"J Endocrinol Invest"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25012261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25012261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T15:44:05Z","timestamp":1770738245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25012261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1530891X25012261"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.09.201","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.09.201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}